Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipidic vector systems for gene transfer

R J Lee1, L Huang

  • 1Endocyte, Inc., West Lafayette, IN 47906, USA. leer@endocyte.wintek.com

Critical Reviews in Therapeutic Drug Carrier Systems
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium.

Gene therapy·1999
Same author

Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applications.

Gene therapy·1999
Same author

A novel T7 RNA polymerase autogene for efficient cytoplasmic expression of target genes.

Gene therapy·1999
Same author

Regulation of F-actin binding to platelet moesin in vitro by both phosphorylation of threonine 558 and polyphosphatidylinositides.

Molecular biology of the cell·1999
Same author

A genetically modified recombinant tumor necrosis factor-alpha conjugated to the distal terminals of liposomal surface grafted polyethyleneglycol chains.

International journal of pharmaceutics·1999
Same author

Separation of nucleotide oligomers by unitary anion-exchange.

Journal of chromatographic science·1999

Nonviral gene delivery systems, particularly lipidic vectors, offer safer and more versatile alternatives to viral vectors. These lipidic gene transfer vehicles show promise for enhanced gene therapy applications due to reduced toxicity and immunogenicity.

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Gene Therapy and Drug Delivery

Background:

  • Effective clinical gene therapy relies on the development of efficient gene transfer vehicles (vectors).
  • Viral vectors are efficient but can cause toxicity and immunogenicity, limiting repeated use.
  • Nonviral vectors, especially lipidic systems, present potential advantages like lower toxicity, larger DNA capacity, targetability, and ease of production.

Purpose of the Study:

  • To summarize recent advancements in lipidic gene delivery vectors for gene therapy.
  • To review factors influencing vector structure and gene delivery efficiency.
  • To discuss gene transfer mechanisms and their impact on vector design.

Main Methods:

  • Review and categorization of three main types of lipidic gene transfer vectors: DNA/cationic liposome complexes, DNA encapsulated in neutral or anionic liposomes, and liposome-entrapped, polycation-condensed DNA (LPDI and LPDII).

Related Experiment Videos

  • Analysis of factors affecting vector structure and gene delivery efficiency.
  • Discussion of potential gene transfer mechanisms.

    • Main Results:

    • Lipidic vectors offer advantages over viral vectors, including reduced toxicity, lack of immunogenicity allowing repeated administration, nonrestrictive DNA cargo size, and potential for targeting.
    • Different types of lipidic vectors (cationic liposomes, encapsulated DNA, liposome-entrapped condensed DNA) exhibit varying characteristics and efficiencies.
    • Vector structure and composition significantly influence gene delivery performance.

    Conclusions:

    • Lipidic gene delivery vectors represent a promising nonviral alternative for gene therapy applications.
    • Understanding the factors affecting vector performance and the mechanisms of gene transfer is crucial for optimizing vector design.
    • The reduced immunogenicity of lipidic vectors facilitates repeated in vivo gene delivery.